Pyxis Oncology, Inc. (PYXS)
3.49
-0.40
(-10.28%)
USD |
NASDAQ |
Sep 09, 14:40
Pyxis Oncology Market Cap : 221.39M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 246.76M |
| September 04, 2026 | 246.76M |
| September 03, 2026 | 226.15M |
| September 02, 2026 | 237.88M |
| September 01, 2026 | 218.22M |
| August 31, 2026 | 205.53M |
| August 28, 2026 | 204.89M |
| August 27, 2026 | 210.60M |
| August 26, 2026 | 211.87M |
| August 25, 2026 | 194.11M |
| August 24, 2026 | 187.77M |
| August 21, 2026 | 195.38M |
| August 20, 2026 | 197.92M |
| August 19, 2026 | 213.78M |
| August 18, 2026 | 189.67M |
| August 17, 2026 | 191.57M |
| August 14, 2026 | 190.94M |
| August 13, 2026 | 190.94M |
| August 12, 2026 | 201.72M |
| August 11, 2026 | 179.52M |
| August 10, 2026 | 242.96M |
| August 07, 2026 | 234.36M |
| August 06, 2026 | 235.62M |
| August 05, 2026 | 196.66M |
| August 04, 2026 | 198.55M |
| Date | Value |
|---|---|
| August 03, 2026 | 191.01M |
| July 31, 2026 | 166.50M |
| July 30, 2026 | 180.33M |
| July 29, 2026 | 183.47M |
| July 28, 2026 | 182.84M |
| July 27, 2026 | 182.84M |
| July 24, 2026 | 163.99M |
| July 23, 2026 | 168.39M |
| July 22, 2026 | 158.96M |
| July 21, 2026 | 140.11M |
| July 20, 2026 | 141.37M |
| July 17, 2026 | 148.28M |
| July 16, 2026 | 140.11M |
| July 15, 2026 | 152.68M |
| July 14, 2026 | 143.88M |
| July 13, 2026 | 153.31M |
| July 10, 2026 | 167.76M |
| July 09, 2026 | 165.87M |
| July 08, 2026 | 169.02M |
| July 07, 2026 | 192.89M |
| July 06, 2026 | 154.56M |
| July 02, 2026 | 165.25M |
| July 01, 2026 | 179.07M |
| June 30, 2026 | 189.12M |
| June 29, 2026 | 179.70M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.797B |
| Alnylam Pharmaceuticals, Inc. | 34.00B |
| Anika Therapeutics, Inc. | 281.44M |
| Savara, Inc. | 1.110B |
| Vericel Corp. | 1.999B |
Market Cap Related Metrics
| PS Ratio | 19.98 |
| Price to Book Value | 19.35 |
| Price | 3.49 |
| Earnings Yield | -40.21% |